Skip to main content
logo
CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea flag South Korea · Delayed Price · Currency is KRW
730.00
-70.00 (-8.75%)
Jul 28, 2026, 3:30 PM KST

CMG Pharmaceutical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Revenue
110,119105,22999,10093,90782,19758,623
Revenue Growth
13.63%6.19%5.53%14.24%40.21%17.56%
Gross Profit
62,57460,87745,64343,59240,75228,885
Operating Income
-5,284-3,6921,0203,0372,9812,604
Net Income
-8,383-10,0772,6956,455-388.143,051
Earnings Per Share
-58.08-69.875.0046.00-3.0025.00
EPS Growth
---89.13%---55.12%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2019
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Cash & Investments
26,57926,50276,79468,82777,813119,574
Total Debt
88,29672,00879,96526,1196,713286.39
Net Cash (Debt)
-61,717-45,506-3,17142,70871,100119,288
Net Cash Growth
----39.93%-40.40%119.02%
Net Cash Per Share
-427.57-315.51-5.88307.49511.91981.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Operating Cash Flow
-10,380-11,020290.093,9384,9382,823
Capital Expenditures
-40,065-29,630-28,098-12,384-8,382-8,176
Free Cash Flow
-50,445-40,650-27,808-8,446-3,444-5,352
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2019
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
Gross Margin
56.82%57.85%46.06%46.42%49.58%49.27%
Operating Margin
-4.80%-3.51%1.03%3.23%3.63%4.44%
Pretax Margin
-9.21%-11.25%2.91%7.17%-1.53%6.54%
Profit Margin
-7.61%-9.58%2.72%6.87%-0.47%5.21%
FCF Margin
-45.81%-38.63%-28.06%-8.99%-4.19%-9.13%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2019
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
PE Ratio
--91.1351.85-193.46
PS Ratio
0.982.612.483.563.6310.07